Synthon Biopharmaceuticals B.V.
USPTO PatentsView assignee record - 10 granted patents across 6 technology areas, recorded in grant years 2016–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).
The verdict
According to USPTO PatentsView, Synthon ranks #27,551 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 6 technology areas.
- #27,551
- of 49,997 US assignees by volume
- 25th percentile
- by Innovation Score (27.8/100)
- 18.1
- avg claims per patent
- -89%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R27551 · Foreign Corporation #27,551 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 10 grants
- MID-PACK #27,551/49,997
- PHOTO-FINISH Sutherland Global…
- CPC-NARROW C07K · 6 areas
- INNOV-THIN 27.8/100
- CLAIMS-RICH 18.1 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -89% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Sutherland Global Services Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Synthon’s 27.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Synthon
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Synthon Biopharmaceu… · this assignee 28
Synthon Biopharmaceu… · this assignee
28 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Synthon's Innovation Score is 27.8/100 (25th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Synthon?
Each dot is one of Synthon’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Synthon’s own 18.1 claims/patent is ABOVE the 13.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Synthon's grants concentrate
Synthon Biopharmaceuticals B.V. is a focused PatentsView assignee: 6 CPC subclasses with 90% of grants classified under C07K (Peptides). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2020. By volume, Synthon sits between Sutherland Global Services Inc. and T. Hasegawa Co., Ltd..
Who files at Synthon's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Sutherland Global…
Sutherland Global Services Inc.
10 patents
- Sway Motorsports
Sway Motorsports LLC
10 patents
- Sympateco
Sympateco, Inc.
10 patents
- Synopsys Taiwan
Synopsys Taiwan Co., Ltd.
10 patents
- Syscend
Syscend, Inc.
10 patents
- Systimmune
SystImmune, Inc.
10 patents
- System Instruments
System Instruments Co. , Ltd.
10 patents
- T Hasegawa
T. Hasegawa Co., Ltd.
10 patents
- Synthon Biopharma… ◀
Synthon Biopharmaceuticals B.V.
10 patents
What this shows Synthon holds 10 patents at rank #27,542, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Synthon
By rank, the assignees closest to #27,542 in granted patent volume.
- Sutherland Global Services Inc. #27,538 · 10 patents
- Sway Motorsports LLC #27,539 · 10 patents
- Sympateco, Inc. #27,540 · 10 patents
- Synopsys Taiwan Co., Ltd. #27,541 · 10 patents
- Syscend, Inc. #27,543 · 10 patents
- SystImmune, Inc. #27,544 · 10 patents
- System Instruments Co. , Ltd. #27,545 · 10 patents
- T. Hasegawa Co., Ltd. #27,546 · 10 patents
Leaders in C07K (Peptides)
Other assignees with the most granted patents in Synthon's primary technology class.
- The Regents of the University of California 894 in class
- Regeneron Pharmaceuticals, Inc. 824 in class
- Immatics Biotechnologies GmbH 678 in class
- Genentech, Inc. 565 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 513 in class
- The Trustees of the University of Pennsylvania 501 in class
- Novartis AG 407 in class
- The Board of Trustees of the Leland Stanford Junior University 400 in class
Synthon's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
28 25th percentile higher than 25% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 20.0% |
| 2017 | 3 | 30.0% |
| 2018 | 2 | 20.0% |
| 2019 | 2 | 20.0% |
| 2020 | 1 | 10.0% |
Which technologies does Synthon Biopharmaceuticals B.V. patent most?
Top 6 of 6 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Synthon Biopharmaceuticals B.V.'s patent record in context - here's where to go next.
- Synthon Biopharmaceuticals B.V.'s lead technology class is C07K (Peptides), 90% of its portfolio - see every assignee active in that class. Explore C07K
- Ranked #27,551 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Synthon Biopharmaceuticals B.V. against Sutherland Global Services Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 27.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.